MENG DING has extensive experience in a broad spectrum of capital markets and M&A transactions, especially in the TMT, healthcare, hard-tech, financial institutions and other emerging technology fields. He has advised on numerous Hong Kong IPOs, U.S. IPOs and follow-on offerings, pre-IPO investments, U.S. public company going-private transactions and Rule 144A and Regulation S bond offerings (investment-grade and high-yield). He also regularly advises U.S.-listed companies on SEC compliance, exchange reporting and other general corporate matters. He currently serves on the firm’s COVID-19 Task Force.
Meng received a Ph.D. from Massachusetts Institute of Technology and holds 31 issued U.S. patents. Earlier in his career, he was a high-tech R&D technologist in Silicon Valley, where he focused on new product development. He stays well connected to the technology community, particularly in the Greater China region.
Meng is a native Mandarin speaker and is fluent in English.
Admissions & Certifications
- New York
- Hong Kong (Solicitor)
- University of California, Berkeley School of Law, J.D.
- Massachusetts Institute of Technology, Ph.D. in Physics
- Peking University, B.S. in Physics
- Chinese - Mandarin